NDC properties for "adalimumab-adaz 40 MG per 0.4 ML Auto-Injector" (RxCUI 2641655)
About this data
The tables show NDC propoerties for adalimumab-adaz 40 MG per 0.4 ML Auto-Injector with the RxCUI 2641655
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for adalimumab-adaz 40 MG per 0.4 ML Auto-Injector (RxCUI 2641655)
BLA | BLA761071 |
---|---|
MMSL_CODE | MTH_RXN_BD39595 |
RxCUI | 2641655 |
SPL_SET_ID | 3468792f-63ef-4916-8ed1-8214f327d9dd |
VUID | 4042388 |
Prescribable Synonym | adalimumab-adaz 40 MG in 0.4 ML Auto-Injector |
RXNAV_STR | 0.4 ML adalimumab-adaz 100 MG/ML Auto-Injector |
RxNorm Name | 0.4 ML adalimumab-adaz 100 MG/ML Auto-Injector |
RxNorm Synonym | adalimumab-adaz 40 MG per 0.4 ML Auto-Injector |
Related queries | Interactions (for RxCUI 2641655) |
NDC Properties
NDC Item 61314032720
NDC 9 | 61314-327 |
---|---|
NDC 10 | 61314-327-20 |
NDC Item | 61314032720 |
Packaging | 2 SYRINGE in 1 CARTON (61314-327-20) / .4 mL in 1 SYRINGE |
BLA | BLA761071 |
FDA SPL set id | 793549 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | BLA |
Marketing effective time low | 2023-07-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 61314-327 |